Enable Injections Announces $215 Million Financing

Enable Injections Announces $215 Million Financing

01/27/22, 10:35 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcincinnati
Money raised
$215 million
Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce $215 million in Series C financing. Magnetar Capital ("Magnetar") led the financing along with new institutional investments from GCM Grosvenor, Squarepoint Capital, Woody Creek Capital Partners, and other investors. Enable received significant continued support from existing investors including Cincinnati Children's Hospital Medical Center, CincyTech, Cintrifuse, and Ohio Innovation Fund.

Company Info

Company
Enable Injections
Location
cincinnati, ohio, united states
Additional Info
Cincinnati-based Enable Injections is an investigational-stage company developing and manufacturing on-body subcutaneous drug delivery systems designed to improve the patient experience, support superior outcomes, and advance healthcare system value and economics. Enable's body-worn enFuse® drug delivery platform utilizes standard container closure systems to deliver high-volume pharmaceutical and biologic therapeutics. For more information, please visit www.enableinjections.com.